Sales is a tough game, and businesses need to treat it like a process.
Territory Mapping is now live on Rare.Monitor. The capability allows pharmaceutical and medical device sales teams to design sales territories based on actual UK clinic distribution, treatment density, and population data, rather than rough geographic divisions or historical patch boundaries that have not been revisited in years.
The development followed sustained client feedback that existing territory tools were too coarse for the way commercial teams now plan. The new capability is built around four functional areas.
Detailed exploration of the UK
Territory Mapping breaks the UK down from broad regions to postcode-level granularity. The dashboard allows teams to click into a region and see the clinics that match their target criteria, surfacing concentration that does not show up at a regional view.
Targeting by treatment density
The platform maps the UK by density of specific treatments offered, not just by clinic location. That distinction matters: a high concentration of clinics in a region is only commercially relevant if those clinics actually offer the treatment category the manufacturer is selling into. Rare.Monitor draws on its provider database to map this directly.
Searching by population size
Population density across the UK varies considerably and needs to factor into how teams allocate effort. Territory Mapping visualises the UK by population density to postcode level, which allows commercial teams to weight territory allocation by addressable patient base, not just by clinic count.
Building effective sales territories
The most commercially significant capability is the ability to design territories. Teams can define territory boundaries, see how many qualifying prospects sit inside each, and balance workload across the field force. That balance is the difference between a territory plan that compounds and one that creates internal disputes about who got the soft patch.
What it means for commercial teams
Field force productivity is one of the largest controllable cost lines in pharmaceutical and medical device commercial operations. Even small improvements in territory design compound across a sales team over a year. Territory Mapping gives commercial directors a way to redesign territories on data, not on negotiation, and to redo it as the market changes.
The capability is available to Rare.Monitor clients now. Demonstrations are available on request through the Rare.Monitor product page.
